231 related articles for article (PubMed ID: 8732713)
1. Can postmenopausal hormone replacement improve plasma lipids in women with diabetes? The Atherosclerosis Risk in Communities Study Investigators.
Robinson JC; Folsom AR; Nabulsi AA; Watson R; Brancati FL; Cai J
Diabetes Care; 1996 May; 19(5):480-5. PubMed ID: 8732713
[TBL] [Abstract][Full Text] [Related]
2. Associations of postmenopausal hormone therapy with markers of hemostasis and inflammation and lipid profiles in diabetic and nondiabetic american Indian women: the strong heart study.
Zhang Y; Howard BV; Cowan LD; Welty TK; Schaefer CF; Wild RA; Yeh J; Lee ET
J Womens Health (Larchmt); 2004 Mar; 13(2):155-63. PubMed ID: 15072729
[TBL] [Abstract][Full Text] [Related]
3. Hormone replacement therapy and its relationship to lipid and glucose metabolism in diabetic and nondiabetic postmenopausal women: results from the Third National Health and Nutrition Examination Survey (NHANES III).
Crespo CJ; Smit E; Snelling A; Sempos CT; Andersen RE;
Diabetes Care; 2002 Oct; 25(10):1675-80. PubMed ID: 12351460
[TBL] [Abstract][Full Text] [Related]
4. Changes in plasma lipids and lipoproteins associated with starting or stopping postmenopausal hormone replacement therapy. Atherosclerosis Risk in Communities Study.
Folsom AR; McGovern PG; Nabulsi AA; Shahar E; Kahn ES; Winkhart SP; White AD
Am Heart J; 1996 Nov; 132(5):952-8. PubMed ID: 8892766
[TBL] [Abstract][Full Text] [Related]
5. How HRT Alters the Lipid Profile in Women with Diabetes.
Robinson JG
Medscape Womens Health; 1996 Dec; 1(12):4. PubMed ID: 9746662
[TBL] [Abstract][Full Text] [Related]
6. Lipid pattern in middle-aged inhabitants of the Lower Silesian region of Poland. The PURE Poland sub-study.
Skoczyńska A; Wojakowska A; Turczyn B; Zatońska K; Wołyniec M; Regulska-Ilow B; Ilow R; Szuba A; Zatoński W
Ann Agric Environ Med; 2013; 20(2):317-24. PubMed ID: 23772584
[TBL] [Abstract][Full Text] [Related]
7. Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. The Atherosclerosis Risk in Communities Study Investigators.
Nabulsi AA; Folsom AR; White A; Patsch W; Heiss G; Wu KK; Szklo M
N Engl J Med; 1993 Apr; 328(15):1069-75. PubMed ID: 8384316
[TBL] [Abstract][Full Text] [Related]
8. Factors associated with plasma lipids and lipoproteins in type 1 diabetes mellitus: the EURODIAB IDDM Complications Study.
Idzior-Walus B; Mattock MB; Solnica B; Stevens L; Fuller JH;
Diabet Med; 2001 Oct; 18(10):786-96. PubMed ID: 11678968
[TBL] [Abstract][Full Text] [Related]
9. Effects of menopause, gender and age on lipids and high-density lipoprotein cholesterol subfractions.
Anagnostis P; Stevenson JC; Crook D; Johnston DG; Godsland IF
Maturitas; 2015 May; 81(1):62-8. PubMed ID: 25804951
[TBL] [Abstract][Full Text] [Related]
10. Effects of transdermal estrogen replacement therapy on plasma levels of nitric oxide and plasma lipids in postmenopausal women.
Balci H; Altunyurt S; Acar B; Fadiloglu M; Kirkali G; Onvural B
Maturitas; 2005 Apr; 50(4):289-93. PubMed ID: 15780528
[TBL] [Abstract][Full Text] [Related]
11. ESR1 and APOE gene polymorphisms, serum lipids, and hormonal replacement therapy.
Almeida S; Fiegenbaum M; de Andrade FM; Osório-Wender MC; Hutz MH
Maturitas; 2006 May; 54(2):119-26. PubMed ID: 16242874
[TBL] [Abstract][Full Text] [Related]
12. Elevated remnant-like particle cholesterol and triglyceride levels in diabetic men and women in the Framingham Offspring Study.
Schaefer EJ; McNamara JR; Shah PK; Nakajima K; Cupples LA; Ordovas JM; Wilson PW;
Diabetes Care; 2002 Jun; 25(6):989-94. PubMed ID: 12032104
[TBL] [Abstract][Full Text] [Related]
13. [Effect of hormone replacement therapy on blood serum lipids in postmenopausal women with type 2 diabetes].
Kozlov SG; Dotsenko IuV; Sankova AV; Liakishev AA; Tvorogova MG; Afanas'eva OI; Titov VN; Pokrovskiĭ SN; Naumov VG
Kardiologiia; 2002; 42(7):47-52. PubMed ID: 12494113
[TBL] [Abstract][Full Text] [Related]
14. [Postmenopausal women: changes in plasma lipids with different estrogen replacement therapies].
Blumel JE; Brandt A; Garabagno A; Cubillos M; Lozano A
Rev Med Chil; 1990 Apr; 118(4):382-7. PubMed ID: 2133147
[TBL] [Abstract][Full Text] [Related]
15. The association of elective hormone therapy with changes in lipids among glucose intolerant postmenopausal women in the diabetes prevention program.
Golden SH; Kim C; Barrett-Connor E; Nan B; Kong S; Goldberg R;
Metabolism; 2013 Sep; 62(9):1313-22. PubMed ID: 23660512
[TBL] [Abstract][Full Text] [Related]
16. Effect of hormone replacement therapy on lipoprotein(a) and lipid levels in postmenopausal women. Influence of various progestogens and duration of therapy.
Kim CJ; Min YK; Ryu WS; Kwak JW; Ryoo UH
Arch Intern Med; 1996 Aug 12-26; 156(15):1693-700. PubMed ID: 8694668
[TBL] [Abstract][Full Text] [Related]
17. Association of hormone replacement therapy and carotid wall thickness in women with and without diabetes.
Dubuisson JT; Wagenknecht LE; D'Agostino RB; Haffner SM; Rewers M; Saad MF; Laws A; Herrington DM
Diabetes Care; 1998 Nov; 21(11):1790-6. PubMed ID: 9802722
[TBL] [Abstract][Full Text] [Related]
18. Hormone replacement therapy in postmenopausal women protects against smoking-induced changes in vascular structure and function.
Teede HJ; Liang YL; Shiel LM; McNeil JJ; McGrath BP
J Am Coll Cardiol; 1999 Jul; 34(1):131-7. PubMed ID: 10400001
[TBL] [Abstract][Full Text] [Related]
19. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
Davis SR; Goldstat R; Newman A; Berry K; Burger HG; Meredith I; Koch K
Climacteric; 2002 Dec; 5(4):341-50. PubMed ID: 12626213
[TBL] [Abstract][Full Text] [Related]
20. Effects of transdermal and oral estrogen replacement on lipids and glucose metabolism in postmenopausal women with type 2 diabetes mellitus.
Araújo DA; Farias ML; Andrade AT
Climacteric; 2002 Sep; 5(3):286-92. PubMed ID: 12419087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
